Cholesterol embolization (CE) is a potentially serious complication associated with invasive arterial maneuvers, in which standard therapy has not been established. We experienced two cases of CE in patients with severe atherosclerosis whose renal function deteriorated within a few months after invasive arterial maneuvers. CE was confirmed either by renal biopsy (case 1) or skin biopsy (case 2). Oral administration of prednisolone at a daily dose of 30 mg (0.4 mg/kg) was effective to improve their renal function. Our observation suggests that corticosteroid therapy may be beneficial in some patients with CE.
Get full access to this article
View all access options for this article.
References
1.
Applebaum RM, Kronzon I: Evaluation and management of cholesterol embolization and the blue toe syndrome. Curr Opin Cardiol11:533-542, 1996.
2.
Scolari F, Tardanico R, Zani R, et al: Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis36:1089-1109, 2000.
3.
Fine MJ, Kapoor W, Falanga V: Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology38:769-784, 1987.
4.
Baumann DS, McGraw D, Rubin BG, et al: An institutional experience with arterial atheroembolism. Ann Vasc Surg8:258-265, 1994.
5.
Drost H, Buis B, Haan D, et al: Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J52:339-342, 1984.
6.
Johnson LW, Esente P, Giambartolomei A, et al: Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovasc Diagn31:165-172, 1996.
7.
Saklayen MG, Gupta S, Suryaprasad A, et al: Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Angiology48:609-613, 1997.
8.
Eggebrecht H, Oldenburg O, Dirsch O, et al: Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Cathet Cardiovasc Interv49:389-394, 2000.
9.
Karalis DG, Quinn V, Victor MF, et al: Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J131:1149-1155, 1996.
10.
Hyman BT, Landas SK, Ashman RF, et al: Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med82:1233-1237, 1987.
Vacher-Coponat H, Pache X, Dussol B, et al: Pulmonary-renal syndrome responding to corticosteroids: Consider cholesterol embolization. Nephrol Dial Transplant12:1977-1979, 1997.
13.
Woolfson RG, Lachmann H: Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet351:1331-1332, 1998.
14.
Ferrari E, Taillan B, Drai E, et al: Investigation of the thoracic aorta in cholesterol embolism by transoesophageal echocardiography. Heart79:133-136, 1998.
15.
Fabbian F, Catalano C, Lambertini D, et al: A possible role of corticosteroids in cholesterol crystal embolization. Nephron83:189-190, 1999.
16.
Stabellini N, Rizzioli E, Trapassi MR, et al: Renal cholesterol microembolism: Is steroid therapy effective? Nephron86:239-240, 2000.
17.
Hasegawa M, Kawashima S, Shikano M, et al: The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases. Am J Nephrol20:263-267, 2000.
18.
Nakahama H, Sakaguchi K: Small dose oral corticosteroid treatment rapidly improved renal function in a patient with an acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant16:872-873, 2001.
19.
Mann SJ, Sos TA: Treatment of atheroembolization with corticosteroids. Am J Hypertens14:831-834, 2001.
20.
Graziani G, Santostasi S, Angelini C, et al: Corticosteroids in cholesterol emboli syndrome. Nephron87:371-373, 2001.
21.
Elinav E, Chajek-Shaul T, Stern M: Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ324:268-269, 2002.
22.
Belenfant X, Meyrier A, Jacquot C: Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis33:840-850, 1999.
23.
Kaufman JL, Stark K, Brolin RE: Disseminated atheroembolism from extensive degenerative atherosclerosis of the aorta. Surgery102:63-70, 1987.
24.
Colt HG, Begg RJ, Saporito JJ, et al: Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine (Baltimore)67:389-400, 1988.
25.
Ogan E, Schandene L, Papadopoulos T, et al: Interleukin-5 production by T lymphocytes in atheroembolic disease with hypereosinophilia. J Allergy Clin Immunol96:427-429, 1995.
